Related references
Note: Only part of the references are listed.Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies
Katie M. Leick et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial
Vivian P. Bastiaenen et al.
BMC CANCER (2019)
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)
Koen P. Rovers et al.
BMC CANCER (2019)
Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)
Koen P. Rovers et al.
BMJ OPEN (2019)
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions
Sergio Villatoro et al.
MOLECULAR ONCOLOGY (2019)
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial
Nadine Leonie de Boer et al.
BMJ OPEN (2019)
Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival
Joel M. Baumgartner et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Application of Cell-free DNA Analysis to Cancer Treatment
Ryan B. Corcoran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
J. Vidal et al.
ANNALS OF ONCOLOGY (2017)
Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study
Lieke G. E. M. Razenberg et al.
EUROPEAN JOURNAL OF CANCER (2016)
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum
Lieselotte Lemoine et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG)
Joost Huiskens et al.
BMC CANCER (2015)
Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
Lydia G. M. van der Geest et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin
T. R. van Oudheusden et al.
SCIENTIFIC REPORTS (2015)
Patterns of metachronous metastases after curative treatment of colorectal cancer
Yvette R. B. M. van Gestel et al.
CANCER EPIDEMIOLOGY (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?
Diane Goere et al.
ANNALS OF SURGERY (2013)
Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics
Csilla Hasovits et al.
CLINICAL PHARMACOKINETICS (2012)
Peritoneal carcinomatosis of colorectal origin - Incidence and current treatment strategies
MJ Koppe et al.
ANNALS OF SURGERY (2006)
Peritoneal carcinomatosis from colorectal or appendiceal origin:: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement
E De Bree et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Share Paper
